Pharma Marketing Network

Today’s physician interactions are shorter than ever. In many markets, pharmaceutical sales representatives have only a few minutes to deliver relevant information before the conversation shifts or ends. As a result, the traditional Interactive Visual Aid (IVA), built around a fixed, linear presentation, no longer matches how healthcare professionals engage with content. Inst...

The remarkable success of GLP-1 receptor agonists has become one of the biggest healthcare stories of the decade. Originally developed for type 2 diabetes, brands like Ozempic®, Wegovy®, Mounjaro®, and Zepbound® have dramatically expanded the conversation around obesity treatment. However, the impact extends far beyond weight management. Today, pharmaceutical companies across...

In pharmaceutical marketing, credibility has traditionally been tied to academic achievement, published research, and leadership positions within major healthcare institutions. However, the way healthcare professionals discover, discuss, and share clinical information has changed dramatically. Today, many physicians, pharmacists, nurses, and researchers turn to LinkedIn, X, p...

Investors have traditionally judged pharmaceutical companies by one question: What’s in the pipeline? While innovative therapies and clinical milestones remain essential, they no longer tell the whole story. Today, investors are taking a broader view by examining how effectively companies bring products to market, earn stakeholder trust, and sustain commercial succes...

Strong clinical evidence alone no longer guarantees commercial success. Even products backed by excellent clinical data can lose momentum when their messaging fails to evolve alongside physician expectations. That is why effective pharma brand positioning has become one of the highest strategic priorities for today’s pharmaceutical marketers.

Healthcar...